Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.575
+0.365 (30.17%)
Mar 20, 2026, 2:49 PM EDT - Market open
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $1.85 million as of March 20, 2026. Its market cap has decreased by -68.58% in one year.
Market Cap
1.85M
Enterprise Value
-3.02M
1-Year Change
-68.58%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $1.85M, a decrease of -96.78%. That is a compound annual growth rate of -52.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 2.89M | -53.21% |
| Dec 31, 2025 | 6.17M | 124.01% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scinai Immunotherapeutics | 2.18M |
| BioRestorative Therapies | 2.16M |
| Bone Biologics | 2.15M |
| Azitra | 2.15M |
| KALA BIO | 1.94M |
| Onconetix | 1.83M |
| Propanc Biopharma | 1.76M |
| Jaguar Health | 1.64M |